![](/img/cover-not-exists.png)
Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas
Weidmann, E., Neumann, A., Fauth, F., Atmaca, A., Al-Batran, S. E., Pauligk, C., Jager, E.Volume:
22
Year:
2011
Language:
english
Pages:
6
DOI:
10.1093/annonc/mdq671
File:
PDF, 107 KB
english, 2011